{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T01:56:19Z","timestamp":1792806979965,"version":"4.5.0"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2021,3,18]],"date-time":"2021-03-18T00:00:00Z","timestamp":1616025600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,3,18]],"date-time":"2021-03-18T00:00:00Z","timestamp":1616025600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Exp Metastasis"],"published-print":{"date-parts":[[2021,6]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Peritoneal metastases (PM) from lung cancer are rare and it is unknown how they affect the prognosis of patients with lung cancer. This population-based study aimed to assess the incidence, associated factors, treatment and prognosis of PM from lung cancer. Data from the Netherlands Cancer Registry were used. All patients diagnosed with lung cancer between 2008 and 2018 were included. Logistic regression analysis was performed to identify factors associated with the presence of PM. Cox regression analysis was performed to identify factors associated with the overall survival (OS) of patients with PM. Between 2008 and 2018, 129,651 patients were diagnosed with lung cancer, of whom 2533 (2.0%) patients were diagnosed with PM. The European Standardized Rate of PM increased significantly from 0.6 in 2008 to 1.4 in 2018 (p\u2009&lt;\u20090.001). Age between 50 and 74\u00a0years, T3\u20134 tumour stage, N2\u20133 nodal stage, tumour morphology of a small cell lung cancer or adenocarcinoma, and the presence of systemic metastases were associated with the presence of PM. The median OS of patients with PM was 2.5\u00a0months. Older age, male sex, T3\u20134 tumour stage, N2\u20133 nodal stage, not receiving systemic treatment, and the presence of systemic metastases were associated with a worse OS. Synchronous PM were diagnosed in 2.0% of patients with lung cancer and resulted in a very poor survival.<\/jats:p>","DOI":"10.1007\/s10585-021-10085-z","type":"journal-article","created":{"date-parts":[[2021,3,18]],"date-time":"2021-03-18T21:44:51Z","timestamp":1616103891000},"page":"295-303","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Synchronous peritoneal metastases from lung cancer: incidence, associated factors, treatment and survival: a Dutch population-based study"],"prefix":"10.1007","volume":"38","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2692-0994","authenticated-orcid":false,"given":"Robin J.","family":"Lurvink","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anouk","family":"Rijken","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Checca","family":"Bakkers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mieke J.","family":"Aarts","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter W. A.","family":"Kunst","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ben E.","family":"van de Borne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Felice N.","family":"van Erning","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ignace H. J. T.","family":"de Hingh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,3,18]]},"reference":[{"issue":"6","key":"10085_CR1","doi-asserted-by":"publisher","first-page":"1374","DOI":"10.1016\/j.ejca.2012.12.027","volume":"49","author":"J Ferlay","year":"2013","unstructured":"Ferlay J, Steliarova-Foucher E, Lortet-Tieulent J, Rosso S, Coebergh JW, Comber H et al (2013) Cancer incidence and mortality patterns in Europe: estimates for 40 countries in 2012. Eur J Cancer 49(6):1374\u20131403","journal-title":"Eur J Cancer"},{"issue":"5","key":"10085_CR2","doi-asserted-by":"publisher","first-page":"E359","DOI":"10.1002\/ijc.29210","volume":"136","author":"J Ferlay","year":"2015","unstructured":"Ferlay J, Soerjomataram I, Dikshit R, Eser S, Mathers C, Rebelo M et al (2015) Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer 136(5):E359\u2013E386","journal-title":"Int J Cancer"},{"key":"10085_CR3","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1016\/j.ejca.2018.07.005","volume":"103","author":"J Ferlay","year":"2018","unstructured":"Ferlay J, Colombet M, Soerjomataram I, Dyba T, Randi G, Bettio M et al (2018) Cancer incidence and mortality patterns in Europe: estimates for 40 countries and 25 major cancers in 2018. Eur J Cancer 103:356\u2013387","journal-title":"Eur J Cancer"},{"key":"10085_CR4","unstructured":"Lung Cancer: Netherlands Cancer Registry. www.cijfersoverkanker.nl. Accessed in 03-2020"},{"key":"10085_CR5","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.lungcan.2016.03.007","volume":"96","author":"T Patil","year":"2016","unstructured":"Patil T, Aisner DL, Noonan SA, Bunn PA, Purcell WT, Carr LL et al (2016) Malignant pleural disease is highly associated with subsequent peritoneal metastasis in patients with stage IV non-small cell lung cancer independent of oncogene status. Lung Cancer 96:27\u201332","journal-title":"Lung Cancer"},{"issue":"6","key":"10085_CR6","first-page":"1305","volume":"8","author":"H Satoh","year":"2001","unstructured":"Satoh H, Ishikawa H, Yamashita YT, Kurishima K, Ohtsuka M, Sekizawa K (2001) Peritoneal carcinomatosis in lung cancer patients. Oncol Rep 8(6):1305\u20131307","journal-title":"Oncol Rep"},{"issue":"11","key":"10085_CR7","doi-asserted-by":"publisher","first-page":"1811","DOI":"10.1016\/j.ejso.2018.07.049","volume":"44","author":"M Flanagan","year":"2018","unstructured":"Flanagan M, Solon J, Chang KH, Deady S, Moran B, Cahill R et al (2018) Peritoneal metastases from extra-abdominal cancer\u2014a population-based study. Eur J Surg Oncol 44(11):1811\u20131817","journal-title":"Eur J Surg Oncol"},{"issue":"5","key":"10085_CR8","doi-asserted-by":"publisher","first-page":"e126","DOI":"10.1111\/ajco.13131","volume":"15","author":"JF Hsu","year":"2019","unstructured":"Hsu JF, Lee YL, Chang HL, Wei PJ, Shen YT, Lin CM et al (2019) Clinical efficacy of concurrent bevacizumab for malignant ascites in nonsquamous cell carcinoma of the lung. Asia Pac J Clin Oncol 15(5):e126\u2013e131","journal-title":"Asia Pac J Clin Oncol"},{"issue":"39","key":"10085_CR9","doi-asserted-by":"publisher","first-page":"5489","DOI":"10.3748\/wjg.v18.i39.5489","volume":"18","author":"YL Klaver","year":"2012","unstructured":"Klaver YL, Lemmens VE, Nienhuijs SW, Luyer MD, de Hingh IH (2012) Peritoneal carcinomatosis of colorectal origin: incidence, prognosis and treatment options. World J Gastroenterol 18(39):5489\u20135494","journal-title":"World J Gastroenterol"},{"issue":"1","key":"10085_CR10","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1097\/MPA.0b013e31825abf8c","volume":"42","author":"I Thomassen","year":"2013","unstructured":"Thomassen I, Lemmens VE, Nienhuijs SW, Luyer MD, Klaver YL, de Hingh IH (2013) Incidence, prognosis, and possible treatment strategies of peritoneal carcinomatosis of pancreatic origin: a population-based study. Pancreas 42(1):72\u201375","journal-title":"Pancreas"},{"issue":"3","key":"10085_CR11","doi-asserted-by":"publisher","first-page":"622","DOI":"10.1002\/ijc.28373","volume":"134","author":"I Thomassen","year":"2014","unstructured":"Thomassen I, van Gestel YR, van Ramshorst B, Luyer MD, Bosscha K, Nienhuijs SW et al (2014) Peritoneal carcinomatosis of gastric origin: a population-based study on incidence, survival and risk factors. Int J Cancer 134(3):622\u2013628","journal-title":"Int J Cancer"},{"issue":"5","key":"10085_CR12","doi-asserted-by":"publisher","first-page":"e58","DOI":"10.3802\/jgo.2020.31.e58","volume":"31","author":"L Burg","year":"2020","unstructured":"Burg L, Timmermans M, van der Aa M, Boll D, Rovers K, de Hingh I et al (2020) Incidence and predictors of peritoneal metastases of gynecological origin: a population-based study in the Netherlands. J Gynecol Oncol 31(5):e58","journal-title":"J Gynecol Oncol"},{"issue":"3","key":"10085_CR13","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1056\/NEJMoa1708618","volume":"378","author":"WJ van Driel","year":"2018","unstructured":"van Driel WJ, Koole SN, Sonke GS (2018) Hyperthermic intraperitoneal chemotherapy in ovarian cancer. N Engl J Med 378(3):230\u2013240","journal-title":"N Engl J Med"},{"key":"10085_CR14","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1002\/ijc.32750","volume":"147","author":"KD van der Willik","year":"2019","unstructured":"van der Willik KD, Ruiter R, van Rooij FJA, Verkroost-van Heemst J, Hogewoning SJ, Timmermans K et al (2019) Ascertainment of cancer in longitudinal research: the concordance between the Rotterdam Study and the Netherlands Cancer Registry. Int J Cancer 147:633\u2013640","journal-title":"Int J Cancer"},{"issue":"3","key":"10085_CR15","first-page":"140","volume":"40","author":"A Fritz","year":"2013","unstructured":"Fritz A (2013) ICD-O-3 terminology approved for use with cases diagnosed January 1, 2014 and after. J Regist Manag 40(3):140\u2013143","journal-title":"J Regist Manag"},{"key":"10085_CR16","unstructured":"Fritz A, Constance P, Andrew J, Shanmugaratnam K, Sobin LH (2000) International classification of diseases for oncology, 3rd edn. World Health Organization"},{"key":"10085_CR17","unstructured":"Revision of the European Standard Population\u2014Report of Eurostat\u2019s task force. Eurostat (2013)"},{"issue":"12","key":"10085_CR18","doi-asserted-by":"publisher","first-page":"e0189251","DOI":"10.1371\/journal.pone.0189251","volume":"12","author":"S Brinkhof","year":"2017","unstructured":"Brinkhof S, Groen HJM, Siesling SS, IJzerman MJ (2017) Resource utilization in lung cancer diagnostic procedures: current use and budget consequences. PLoS One 12(12):e0189251","journal-title":"PLoS One"},{"key":"10085_CR19","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1186\/s12885-016-2169-5","volume":"16","author":"FY Niu","year":"2016","unstructured":"Niu FY, Zhou Q, Yang JJ, Zhong WZ, Chen ZH, Deng W et al (2016) Distribution and prognosis of uncommon metastases from non-small cell lung cancer. BMC Cancer 16:149","journal-title":"BMC Cancer"},{"issue":"3","key":"10085_CR20","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1111\/j.1440-1843.2008.01268.x","volume":"13","author":"H Su","year":"2008","unstructured":"Su H, Tsai C, Perng R (2008) Peritoneal carcinomatosis in lung cancer. Respirology 13(3):465\u2013467","journal-title":"Respirology"},{"issue":"8","key":"10085_CR21","doi-asserted-by":"publisher","first-page":"1486","DOI":"10.1002\/1097-0142(19870415)59:8<1486::AID-CNCR2820590815>3.0.CO;2-W","volume":"59","author":"PM McNeill","year":"1987","unstructured":"McNeill PM, Wagman LD, Neifeld JP (1987) Small bowel metastases from primary carcinoma of the lung. Cancer 59(8):1486\u20131489","journal-title":"Cancer"},{"issue":"1","key":"10085_CR22","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1002\/1097-0142(1950)3:1<74::AID-CNCR2820030111>3.0.CO;2-7","volume":"3","author":"HL Abrams","year":"1950","unstructured":"Abrams HL, Spiro R, Goldstein N (1950) Metastases in carcinoma; analysis of 1000 autopsied cases. Cancer 3(1):74\u201385","journal-title":"Cancer"},{"key":"10085_CR23","first-page":"467","volume":"78","author":"S Warren","year":"1964","unstructured":"Warren S, Gates O (1964) Lung cancer and metastasis. Arch Pathol 78:467\u2013473","journal-title":"Arch Pathol"},{"issue":"7","key":"10085_CR24","doi-asserted-by":"publisher","first-page":"1135","DOI":"10.1016\/0959-8049(95)00664-8","volume":"32A","author":"G Buccheri","year":"1996","unstructured":"Buccheri G, Ferrigno D, Tamburini M (1996) Karnofsky and ECOG performance status scoring in lung cancer: a prospective, longitudinal study of 536 patients from a single institution. Eur J Cancer 32A(7):1135\u20131141","journal-title":"Eur J Cancer"},{"issue":"7","key":"10085_CR25","doi-asserted-by":"publisher","first-page":"1087","DOI":"10.1093\/annonc\/mdf187","volume":"13","author":"E Radzikowska","year":"2002","unstructured":"Radzikowska E, Glaz P, Roszkowski K (2002) Lung cancer in women: age, smoking, histology, performance status, stage, initial treatment and survival. Population-based study of 20 561 cases. Ann Oncol 13(7):1087\u20131093","journal-title":"Ann Oncol"},{"issue":"2","key":"10085_CR26","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1097\/JTO.0b013e3181622c17","volume":"3","author":"RC Lilenbaum","year":"2008","unstructured":"Lilenbaum RC, Cashy J, Hensing TA, Young S, Cella D (2008) Prevalence of poor performance status in lung cancer patients: implications for research. J Thorac Oncol 3(2):125\u2013129","journal-title":"J Thorac Oncol"},{"key":"10085_CR27","doi-asserted-by":"crossref","unstructured":"Lurvink RJ, Bakkers C, Rijken A, Van Erning FN, Nienhuijs SW, Burger JW et al (2020) Increase in the incidence of synchronous and metachronous peritoneal metastases in patients with colorectal cancer: a nationwide study. EJSO (submitted for publication)","DOI":"10.1016\/j.ejso.2020.11.135"},{"key":"10085_CR28","unstructured":"Rijken A, Bakkers C, Van Erning FN, Van der Geest LG, De Vos-Geelen J, Besselink MGH et al (2020) Addressing the increasing incidence of synchronous pancreatic peritoneal metastases: treatment strategies and survival in a nationwide cohort. Pancreas (submitted for publication)"},{"key":"10085_CR29","doi-asserted-by":"crossref","unstructured":"Bakkers C, Lurvink RJ, Van Erning FN, Rijken A, Nienhuijs SW, Burger JW et al (2020) Treatment strategies and prognosis in patients with synchronous or metachronous colorectal peritoneal metastases: a population-based study. Ann Surg Oncol (submitted for publication)","DOI":"10.1245\/s10434-021-10190-z"}],"container-title":["Clinical &amp; Experimental Metastasis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10585-021-10085-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10585-021-10085-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10585-021-10085-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,6,5]],"date-time":"2021-06-05T08:11:17Z","timestamp":1622880677000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10585-021-10085-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3,18]]},"references-count":29,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2021,6]]}},"alternative-id":["10085"],"URL":"https:\/\/doi.org\/10.1007\/s10585-021-10085-z","relation":{},"ISSN":["0262-0898","1573-7276"],"issn-type":[{"value":"0262-0898","type":"print"},{"value":"1573-7276","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,3,18]]},"assertion":[{"value":"12 January 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 March 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 March 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Ignace de Hingh reported an unrestricted research grand outside the submitted work from RanD\/QPS and Roche, paid to the institute. The other authors reported no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}